Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Kaisa, Auvinen"'
Cancer growth is regulated by several nonmalignant cell types, such as leukocytes and endothelial cells, which reside in the stroma of the tumor. Vascular adhesion protein-1 (VAP-1) is an amine oxidase enzyme that is expressed on the surface of endot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afcf749f0f09c2b9f5a9cbcf5f4269df
https://doi.org/10.1158/0008-5472.c.6499112.v1
https://doi.org/10.1158/0008-5472.c.6499112.v1
Supplementary Figure 1 from Vascular Adhesion Protein-1 Enhances Tumor Growth by Supporting Recruitment of Gr-1+CD11b+ Myeloid Cells into Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f2be2d6373cded9a6be21429c5448c7
https://doi.org/10.1158/0008-5472.22379057
https://doi.org/10.1158/0008-5472.22379057
Supplementary Figure 4 from Vascular Adhesion Protein-1 Enhances Tumor Growth by Supporting Recruitment of Gr-1+CD11b+ Myeloid Cells into Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::793b6c2f3e96b4ef5909d98bda0b0e44
https://doi.org/10.1158/0008-5472.22379048
https://doi.org/10.1158/0008-5472.22379048
Supplementary Figure 3 from Vascular Adhesion Protein-1 Enhances Tumor Growth by Supporting Recruitment of Gr-1+CD11b+ Myeloid Cells into Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::312dab3ce9890c905e73aebfad403531
https://doi.org/10.1158/0008-5472.22379051
https://doi.org/10.1158/0008-5472.22379051
Supplementary Figure 2 from Vascular Adhesion Protein-1 Enhances Tumor Growth by Supporting Recruitment of Gr-1+CD11b+ Myeloid Cells into Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ce724e4d15a440df3d863650791c560
https://doi.org/10.1158/0008-5472.22379054
https://doi.org/10.1158/0008-5472.22379054
Supplementary Methods, Figure Legends 1-4 from Vascular Adhesion Protein-1 Enhances Tumor Growth by Supporting Recruitment of Gr-1+CD11b+ Myeloid Cells into Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c79829d8fe2b23204f8ce8432275d122
https://doi.org/10.1158/0008-5472.22379045
https://doi.org/10.1158/0008-5472.22379045
Autor:
Jeroen Pouwels, Nicola De Franceschi, Pia Rantakari, Kaisa Auvinen, Marika Karikoski, Elina Mattila, Christopher Potter, John P. Sundberg, Nancy Hogg, Carl G. Gahmberg, Marko Salmi, Johanna Ivaska
Publikováno v:
Cell Reports, Vol 5, Iss 3, Pp 619-628 (2013)
SHARPIN-deficient mice display a multiorgan chronic inflammatory phenotype suggestive of altered leukocyte migration. We therefore studied the role of SHARPIN in lymphocyte adhesion, polarization, and migration. We found that SHARPIN localizes to the
Externí odkaz:
https://doaj.org/article/2b3be2b25fb242379c481e2f87104796
Autor:
Pia Rantakari, Saila Kauhanen, Erika Hoppela, Mervi Laukka, Kerstin Thol, Heidi Gerke, Pirjo Merilahti, Kaisa Auvinen, Pauliina Hartiala, Jemiina Salo, Marko Salmi, Emilia Peuhu, Katri Orte, Tove J. Grönroos
Publikováno v:
Journal of Gastrointestinal Surgery
Background Adhesion formation contributes to postoperative complications in abdominal and gynaecological surgery. Thus far, the prevention and treatment strategies have focused on mechanical barriers in solid and liquid form, but these methods are no
Autor:
Gennady G. Yegutkin, Kaisa Auvinen, Marika Karikoski, Pia Rantakari, Heidi Gerke, Kati Elima, Mikael Maksimow, Ileana B. Quintero, Pirkko Vihko, Marko Salmi, Sirpa Jalkanen
Publikováno v:
Mediators of Inflammation, Vol 2014 (2014)
CD73, ecto-5′-nucleotidase, is the key enzyme catalyzing the conversion of extracellular AMP to adenosine that controls vascular permeability and immunosuppression. Also prostatic acid phosphatase (PAP) possesses ecto-5′-nucleotidase/AMPase activ
Externí odkaz:
https://doaj.org/article/26c6a64f5c944cc3a3f5370f6e65198f
Autor:
Norbert, Lubenow, Marja-Kaisa, Auvinen
Publikováno v:
Lakartidningen. 118
Blood transfusions are still associated with risk for adverse events despite a long tradition for improvement of safety. The incidence of reactions is reported to be about 78/100 000 transfusions with 25 % of these being serious. Some types of reacti